FORM 10-QSB

                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, D.C. 20549


[x]     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
        EXCHANGE ACT OF 1934

                For the Quarterly Period Ended April 30, 2006


                           Commission File Number: 0-10315


                            IMPLANTABLE VISION, INC.

             (Exact name of registrant as specified in its charter)

                     (Formerly Baymark Technologies, Inc.)


                 Utah                                          95-4091368
        (State or other jurisdiction of                      (I.R.S. Employer
        incorporation or organization)                       Identification No.)

25730 Lorain Road, North Olmsted, Ohio                      44070
----------------------------------                         --------
(Address of principal executive offices)                   (Zip Code)

Issuer's telephone number, including area code: (212)-835-6198

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2)  has  been  subject  to the  filing
requirements for at least the past 90 days.

              Yes X     No
               -----    -----

Indicate by check mark whether the  registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act). Yes [__] No [X]

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date.


The  number of shares outstanding of  the issuer's common stock, par value $.001
per share, at April 30, 2006, was 30,372,200 shares.

<PAGE>
                            IMPLANTABLE VISION, INC.
                      (FORMERLY BAYMARK TECHNOLOGIES, INC.)

                              FINANCIAL STATEMENTS

                       FOR THE NINE-MONTHS APRIL 30, 2006
                                   (UNAUDITED)







<PAGE>


JASPERS + HALL, PC
CERTIFIED PUBLIC ACCOUNTANTS
--------------------------------------------------------------------------------
9175 E. Kenyon Avenue, Suite 100
Denver, CO 80237
303-796-0099


               REPORT ON REVIEW BY REGISTED PUBLIC ACCOUNTING FIRM


Board of Directors
Implantable Visions, Inc.
San Diego, CA


We have reviewed the  accompanying  consolidated  balance  sheet of  Implantable
Vision, Inc., formerly known as Baymark Technologies, Inc., and its subsidiaries
as of April 30, 2006 and the related  consolidated  statement of operations  for
the three and  nine-month  period ended April 30, 2006,  and cash flows for the
nine-month period ended April 30, 2006. These consolidated financial statements
are the responsibility of the Company's management.

We conducted  our review in  accordance  with  standards  of the Public  Company
Accounting  Oversight  Board  (United  States).  A review of  interim  financial
information consists principally of applying analytical  procedures to financial
data and making  inquiries of persons  responsible  for financial and accounting
matters. It is substantially less in scope than an audit conducted in accordance
with auditing  standards  generally accepted in the United States of America and
standards of the PCAOB,  the objective of which is the  expression of an opinion
regarding the consolidated  financial statements taken as a whole.  Accordingly,
we do not express such an opinion.

Based on our review, we are not aware of any material  modifications that should
be made to the accompanying  consolidated financial statements for them to be in
conformity with accounting principles generally accepted in the United States of
America.

The  accompanying  financial  statements  have been  prepared  assuming that the
Company  will  continue  as a  going  concern.  As  described  in  Note 2 to the
financial  statements,  conditions exist which raise substantial doubt about the
Company's  ability to continue as a going concern.  The financial  statements do
not  include  any  adjustments  that  might  result  from  the  outcome  of this
uncertainty.


/s/Jaspers + Hall, PC
June 19, 2006



<PAGE>
<TABLE>
<CAPTION>

                            IMPLANTABLE VISION, INC.
                      (Formerly Baymark Technologies, Inc.)
                           Consolidated Balance Sheet
<S>                                                                                       <C>                <C>


                                                                                            Unaudited           Audited
                                                                                            April 30,           July 31,
                                                                                               2005               2005
                                                                                          ---------------    ---------------

ASSETS:
Current Assets:
    Cash                                                                                      $1,296,761                $ -
                                                                                          ---------------    ---------------

        Total Current Assets                                                                   1,296,761                  -
                                                                                          ---------------    ---------------

Fixed Assets:
     Property & Equipment                                                                         45,114             33,950
     Less Accumulated Depreciation                                                                (4,512)           (33,950)
                                                                                          ---------------    ---------------

          Total Fixed Assets                                                                      40,602               -
                                                                                          ---------------    ---------------

TOTAL ASSETS                                                                                  $1,337,363             $ -
                                                                                          ===============    ===============


LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities:
    Accounts Payable                                                                            $ 27,857           $298,944
    Accruals                                                                                           -            141,573
    Note Payable - Related Party                                                                       -            168,731
    Discontinued Operations Liability                                                                  -                148
                                                                                          ---------------    ---------------

        Total Current Liabilties                                                                  27,857            609,396
                                                                                          ---------------    ---------------

 Stockholders Equity (Deficit):
    Preferred Stock, $.001 par value, 100,000,000 shares authorized                                1,000              1,000
       Series A Convertible preferred stock 1,000,000 shares
       issued and outstanding 2006 and 2005
       Series B Convertible preferred stock 100,000 shares                                             -                100
       issued and outstanding 2006 and 2005
    Common stock, $.001 par value, 150,000,000 shares authorized                                  30,373              6,623
        30,372,200 shares issued and outstanding in April 2006 and
        662,200 issued and outstanding in July 2005.
    Additional Paid-In Capital                                                                10,050,039          7,812,361
    Stock to be Issued                                                                            1,477
    Accumulated deficit                                                                       (8,773,383)        (8,429,480)
                                                                                          ---------------    ---------------

        Total Stockholders' Equity (Deficit)                                                   1,309,506           (609,396)
                                                                                          ---------------    ---------------

TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)                                            $1,337,363             $ -
                                                                                          ===============    ===============
</TABLE>
See Accountants' Review Report

<PAGE>
<TABLE>
<CAPTION>

                            IMPLANTABLE VISION, INC.
                      (Formerly Baymark Technologies, Inc.)
                      Consolidated Statement of Operations


<S>                                                    <C>               <C>                <C>               <C>

                                                             Three-Months Ended                   Nine-Months Ended
                                                        April 30,                            April 30,
                                                       -------------------------------      -------------------------------
                                                           2006              2005               2006              2005
                                                       -------------     -------------      -------------     -------------
Revenue:
    Sales                                                   $ -               $-                $ -               $ -
                                                       -------------     -------------      -------------     -------------
Total Income                                                  -                -                  -                 -
                                                       -------------     -------------      -------------     -------------
Operating Expenses:
     Administrative Expenses                                320,401            -              453,519               -
                                                       -------------     -------------      -------------     -------------
Total Expenses                                              320,401            -              453,519               -
                                                       -------------     -------------      -------------     -------------
Other Income/Expense
    Interest Income                                              30            -                   30
    Forgiveness of Debt                                           -            -              134,396
    Acquisition Cost                                              -            -              (24,810)
                                                       -------------     -------------      -------------     -------------
Net Other Income/Expense                                         30            -              109,616               -
                                                       -------------     -------------      -------------     -------------
Net Loss From Operations                                   (320,371)           -             (343,903)              -
                                                       -------------     -------------      -------------     -------------
Net Gain/Loss                                            $ (320,371)         $ -           $ (343,903)            $ -
                                                       =============     =============      =============     =============
Per Share Information:

     Weighted average number
     of common shares outstanding                        20,645,533          6,596,004        10,762,472          6,596,004
                                                       -------------     -------------      -------------     -------------
Net Loss per common share                                   $ (0.02)             $ -             $ (0.02)             $-
                                                       =============     =============      =============     =============
</TABLE>
See Accountants' Review Report

<PAGE>
<TABLE>
<CAPTION>

                            IMPLANTABLE VISION, INC.
                      (Formerly Baymark Technologies, Inc.
                   Consolidated Stockholders' Equity (Deficit)
                         For Period Ended April 30, 2006


<S>                                <C>          <C>          <C>          <C>         <C>            <C>         <C>



                                             PREFERRED STOCK                                COMMON STOCKS         Additional
                                            SERIES A                 SERIES B                                      Paid-In
                                   # of Shares    Amount     # of Shares    Amount     # of Shares     Amount      Capital
                                   -----------    ------     -----------    ------     -----------     ------      -------

Balance - July 31, 2004             1,000,000    $ 1,000       100,000       $ 100        662,200        $ 663    $ 7,818,321
                                   -----------  ---------   -----------   ---------   ------------   ----------  -------------
Net Loss for Year                           -          -             -           -              -            -              -
                                   -----------  ---------   -----------   ---------   ------------   ----------  -------------
Balance - July 31, 2005             1,000,000      1,000       100,000         100        662,200          663      7,818,321
                                   -----------  ---------   -----------   ---------   ------------   ----------  -------------
Cancelled Stock                             -          -      (100,000)       (100)      (300,000)        (300)           400
Issuance of Stock to Directors              -          -             -           -         10,000           10              -
Issuance of Stock for Acquisition           -          -             -           -     30,000,000       30,000        475,200
Capital Investment - Stock to
be Issued                                   -          -             -           -              -            -        752,242
Capital Investment - Stock to be
Issued                                      -          -             -           -              -            -      1,003,876
Net Loss for Period                         -          -             -           -              -            -              -
                                   -----------  ---------   -----------   ---------   ------------   ----------  -------------
Balance - April 30, 2006            1,000,000     $1,000             -         $ -     30,372,200     $ 30,373   $ 10,050,039
                                   ===========  =========   ===========   =========   ============   ==========  =============
</TABLE>
See Accountants Review Report



<PAGE>

                            IMPLANTABLE VISION, INC.
                      (Formerly Baymark Technologies, Inc.
                   Consolidated Stockholders' Equity (Deficit)
                        For Period Ended April 30, 2006
(continued)

                                           Stocks                        Total
                                           To Be     Accumulated   Stockholders'
                                           Issued        Deficit         Equity
                                           ------        -------         ------



Balance - July 31, 2004                       $  -  $ (8,429,480)    $ (609,396)
                                        ----------  -------------  -------------

Net Loss for Year                                -              -             -
                                        ----------  -------------  -------------

Balance - July 31, 2005                         -     (8,429,480)      (609,396)
                                        ----------  -------------  -------------

Cancelled Stock                                 -              -              -
Issuance of Stock to Directors                  -              -             10
Issuance of Stock for Acquisition               -              -        505,200
Capital Investment - Stock to be
 Issued                                        633             -        752,875
Capital Investment - Stock to be
 Issued                                        844             -      1,004,720
Net Loss for Period                             -       (343,903)      (303,903)
                                        ----------  -------------  -------------

Balance - April 30, 2006                   $ 1,477  $ (8,773,383)    $1,309,506
                                        ==========  =============  =============



See Accountants Review Report

<PAGE>
<TABLE>
<CAPTION>

                            IMPLANTABLE VISION, INC.
                      (Formerly Baymark Technologies, Inc.)
                      Consolidated Statement of Cash Flow

                                Indirect Method

<S>                                                                                                <C>               <C>


                                                                                                          Nine-Months Ended
                                                                                                     April 30,
                                                                                                   --------------------------------
                                                                                                       2006               2005
                                                                                                   --------------    --------------
Cash Flows from Operating Activities:

     Net (Loss)                                                                                       $ (343,903)           $ -
     Issuance of stock for services                                                                           10              -
     Depreciation                                                                                          4,512              -
     Adjustments to reconcile net loss to cash used
        by operating activities
     Decrease in prepaid expenses                                                                              -              -
     Increase in Discontinued Operations                                                                    (148)             -
     (Decrease) Increase in accounts payable and accrued expenses                                       (412,660)             -
                                                                                                   --------------    --------------
Net Cash Used by Operating Activities                                                                   (752,189)             -
                                                                                                   --------------    --------------
Cash flows from Investing Activities:
    Purchase of Property                                                                                 (45,114)             -
                                                                                                   --------------    ---------------
Net Cash used for Investing Activities                                                                   (45,114)             -
                                                                                                   --------------    --------------
Cash Flows from Financing Activities:

     Proceeds from stock issuance                                                                        505,200              -
     Capital Investment - Stocks to be Issued                                                          1,757,595
     Payments to Loans from officers                                                                    (168,731)             -
                                                                                                   --------------    --------------
Net Cash Provided by Financing Activities                                                              2,094,064              -
                                                                                                   --------------    --------------
Net Increase in Cash & Cash Equivalents                                                                1,296,761              -

Beginning Cash & Cash Equivalents                                                                           -                 -
                                                                                                   --------------    --------------
Ending Cash & Cash Equivalents                                                                       $ 1,296,761            $ -
                                                                                                   ==============    ==============

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
     Cash paid for Interest                                                                             $ -                 $ -
                                                                                                   ==============    ==============
     Cash paid for Income Taxes                                                                         $ -                 $ -
                                                                                                   ==============    ==============

NON-CASH TRANSACTIONS
     Common stock issued for services                                                                      $ 10             $ -
                                                                                                   ==============    ===============

</TABLE>
See Accountants Review Report

<PAGE>

                            IMPLANTABLE VISION, INC.
                      (FORMERLY BAYMARK TECHNOLOGIES, INC.)

                              FINANCIAL STATEMENTS

                       FOR THE NINE-MONTHS APRIL 30, 2006
                                   (UNAUDITED)





<PAGE>







                            IMPLANTABLE VISION, INC.
                      (Formerly Baymark Technologies, Inc.)
                          Notes to Financial Statements
                                 April 30, 2006
                                   (Unaudited)





Note 1 - Presentation of Interim Information:

In the opinion of the management of Implantable  Vision,  Inc., the accompanying
unaudited  financial  statements  include  all  normal  adjustments   considered
necessary to present fairly the financial  position as of April 30, 2006 and the
results of  operations  for the three and  nine-months  ended April 30, 2006 and
2005, and cash flows for the nine-months  ended April 30, 2006.  Interim results
are not necessarily indicative of results for a full year.

The  financial  statements  and notes are presented as permitted by Form 10-QSB,
and do not  contain  certain  information  included  in  the  Company's  audited
financial statements and notes for the fiscal year ended July 31, 2005.

Note 2- Capital Stock Transactions:

The  authorized  capital  stock of the Company is  150,000,000  shares of common
stock at $.001 par value and 100,000,000  shares of preferred stock at $.001 par
value. In September 2005 the Company  authorized a 1 for 10 reverse split of all
common stock and cancelled  the Preferred B shares of stock.  All shares and per
share amounts in the accompanying  financial statements of the Company and notes
thereto  have been  retroactively  adjusted  to give the  effects of the reverse
stock split.  The Company has issued an additional  29,710,000  shares of common
stock in the nine months ended April 30,  2006.  The Company  raised  additional
capital  for  1,476,971  shares of stock for  stocks  to be  issued  $1,477  and
additional paid-in capital of $1,756.118.

Note 4 - Subsequent Event:

The Company has received a stock  subscription  of $2,750,000  for an additional
2,310,925 shares of stock, to be funded upon Registration of the shares.

<PAGE>


ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

Cautionary and Forward Looking Statements


     In addition to  statements of historical  fact,  this Form 10-QSB  contains
forward-looking  statements.  The  presentation of future aspects of Implantable
Vision, Inc. , ("Implantable  Vision,  Inc." the "Company" or "issuer") found in
these  statements is subject to a number of risks and  uncertainties  that could
cause  actual  results  to  differ  materially  from  those  reflected  in  such
statements.  Readers  are  cautioned  not  to  place  undue  reliance  on  these
forward-looking  statements,  which reflect management's analysis only as of the
date hereof.  Without  limiting the generality of the  foregoing,  words such as
"may," "will," "expect,"  "believe,"  "anticipate,"  "intend," or "could" or the
negative  variations thereof or comparable  terminology are intended to identify
forward-looking statements.

     These forward-looking statements are subject to numerous assumptions, risks
and uncertainties that may cause Implantable  Vision,  Inc. actual results to be
materially different from any future results expressed or implied by Implantable
Vision, Inc. in those statements. Important facts that could prevent Implantable
Vision,  Inc. from achieving any stated goals  include,  but are not limited to,
the following:

         Some of these risks might include, but are not limited to, the
following:

                  (a)      volatility or decline of the Company's stock price;

                  (b)      potential fluctuation in quarterly results;

                  (c)      failure of the Company to earn revenues or profits;

                  (d)      inadequate capital to continue or expand its busi-
                           ness, inability to raise additional capital or financ
                           -ing to implement its business plans;

                  (e)      failure to achieve any business.

                  (f)      rapid and significant changes in markets;

                  (g)      litigation with or legal claims and allegations by
                           outside parties;

                  (h)      insufficient revenues to cover operating costs.




<PAGE>

         There is no assurance that the Company will be profitable, the Company
may not be able to successfully develop, manage or market its products and
services, the Company may not be able to attract or retain qualified executives
and technology personnel, the Company's products and services may become
obsolete, government regulation may hinder the Company's business, additional
dilution in outstanding stock ownership may be incurred due to the issuance of
more shares, warrants and stock options, or the exercise of warrants and stock
options, and other risks inherent in the Company's businesses.

The Company  undertakes no obligation to publicly  revise these  forward-looking
statements to reflect events or circumstances  that arise after the date hereof.
Readers should  carefully  review the factors  described in other  documents the
Company  files from time to time with the  Securities  and Exchange  Commission,
including the Quarterly  Reports on Form 10-QSB and Annual Report on Form 10-KSB
filed by the Company for fiscal year ended July 31, 2005 and any Current Reports
on Form 8-K filed by the Company.

Changes in Financial Condition

The Company  completed its reverse  acquisition in December 2005 of Jig Jig, LLC
and  changed  its  name  to  Implantable  Vision,  Inc.  The  operations  of the
reorganized/recapitalized company are those of the on going business. As part of
the  reorganization  $414,760 in accounts payable were eliminated and $1,757,595
from a private  placement of stock was  received.  This  resulted in the company
having cash of $1,296,761 approximately, on hand at the end of the quarter.


RESULTS OF OPERATIONS FOR THE QUARTER ENDED APRIL 30, 2006 COMPARED TO THE
SAME PERIOD IN 2005.

During the quarters ended April 30, 2006, and 2005, no operating revenues were
generated. The Company had no other operating income during the quarter.

The company had  administrative  expenses in the quarter in 2006 of $320,401 and
none in 2005.  The company  incurred no operating  expenses in 2006 and 2005, in
the  quarter.  The  net operating loss was  ($320,401)  in the  quarter in 2006
compared to none in the quarter in 2005.

The loss per share was ($.02) in the quarter in 2006 and none in 2005.

The Company expects the trend of operating losses to continue into the future at
an increasing rate, until the company achieves sales of which there is no
assurance.



<PAGE>

RESULTS OF OPERATIONS FOR THE NINE MONTHS ENDED APRIL 30, 2006 COMPARED TO
SAME PERIOD IN 2005.

The Company  experienced a total of $453,519 in  administrative  expenses in the
nine month period ended April 30, 2006 as compared  with none in the same period
a year earlier.  The Company had no operating  expenses in the period in 2006 or
2005.  In the nine month  period  ended April 30,  2006 the Company  settled its
outstanding  payables  and  recorded  $134,396 in  forgiveness  of debt as other
income and incurred acquisition costs of $24,810 and had interest income of $30
for net other income of $109,616.  The Company  incurred a net  loss of
($343,903) in the period in 2006 compared to no loss in the period in 2005.

The profit/loss per share was ($.02) in the nine months ended April, 2006,
compared to none in the same period in 2005.

The Company expects the trend of operating losses to continue into the future at
an increasing rate, until the company achieves sales of which there is no
assurance.

LIQUIDITY AND CAPITAL RESOURCES

     Year to date,  the  company  had no  revenue,  but has  increased  its cash
position  to  $1,296,761  approximately  through  accomplishment  of  a  provate
placement. The company had no other assets of any value at period end.

     The  company's  only capital  resources are its common stock which might be
sold to raise capital.

NEED FOR ADDITIONAL FINANCING

     The Company has  capital  sufficient  to meet the  Company's  current  cash
needs,   including  the  costs  of  compliance  with  the  continuing  reporting
requirements of the Securities Exchange Act of 1934. The Company will seek loans
or equity  placements  to cover future cash needs.  Lack of its capital may be a
sufficient impediment to prevent it from accomplishing the goal of expanding its
operations.

     The Company will need to raise  additional  funds to carry out its business
activities in the next twelve months.

<PAGE>

         Irrespective   of  whether  the  Company's  cash  assets  prove  to  be
inadequate to meet the Company's  operational  needs,  the Company might seek to
compensate providers of services by issuances of stock in lieu of cash.

GOING CONCERN

     The Company's auditor has issued a "going concern" qualification as part of
his opinion in the Audit Report. There is substantial doubt about the ability of
the Company to continue as a "going  concern." At quarter  endthe Company has no
revenue stream, cash of over $1,200,000, minimal other assets, ongoing expenses,
and three conditional subscriptions for $2,750,000.  The effects of such lack of
revenue  could  cause  the  Company's  insolvency,  if a  revenue  stream is not
developed.

ITEM 3.  CONTROLS AND PROCEDURES

a.       Evaluation of Disclosure Controls and Procedures:

Disclosure  controls  and  procedures  are  designed to ensure that  information
required to be  disclosed in the reports  filed or submitted  under the Exchange
Act is recorded,  processed,  summarized  and  reported,  within the time period
specified  in the SEC's  rules and forms.  Disclosure  controls  and  procedures
include,  without  limitation,  controls and procedures  designed to ensure that
information required to be disclosed in the reports filed under the Exchange Act
is accumulated  and  communicated  to management,  including the Chief Executive
Officer and Chief Financial Officer,  as appropriate,  to allow timely decisions
regarding  required  disclosure.  As of the end of the  period  covered  by this
report  April 30,  2006,  the Company  carried  out an  evaluation,  under the
supervision and with the  participation of the Company's  management,  including
the  Company's  Chief  Executive  Officer and Chief  Financial  Officer,  of the
effectiveness of the design and operation of the Company's  disclosure  controls
and  procedures.  Based  upon and as of the date of that  evaluation,  the Chief
Executive  Officer and Chief  Financial  Officer  concluded  that the  Company's
disclosure  controls and  procedures  are  effective to ensure that  information
required to be disclosed in the reports the Company  files and submits under the
Exchange  Act is  recorded,  processed,  summarized  and  reported  as and  when
required.

b.       Changes in Internal Control over Financial Reporting:

There  were no changes  in the small  business  issuers  internal  control  over
financial  reporting  identified  in  connection  with  the  Company  evaluation
required by  paragraph  (d) of Rule 13a-15 or Rule 15d-15 under the Exchange act
that occurred  during the small  business  issuers last fiscal  quarter that has
materially  affected or is  reasonable  likely to materially  affect,  the small
business issuers internal control over financial reporting.

<PAGE>


PART II.  OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

        NONE

ITEM  2. CHANGES IN SECURITIES

        NONE

ITEM  3. DEFAULTS UPON SENIOR SECURITIES

        NONE

ITEM  4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDER

        NONE

ITEM  5.  OTHER INFORMATION

        NONE

ITEM  6. EXHIBITS AND REPORTS ON FORM 8-K

        (a)     32    906 Sarbanes-Oxley Certification
                31    302 Sarbanes-Oxley Certification

        (b)     Reports on Form 8-K.

                None
<PAGE>

  SIGNATURES

In  accordance  with section 13 of the Exchange  Act,  the  registrant  has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.


George Rozakis                             June 23, 2006
- - --------------------------------------------------------
/s/George Rozakis                             President